Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Terui

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
Blood Cancer Journal|April 22, 2017
Low absolute peripheral blood CD4+ T-cell count predicts poor prognosis in R-CHOP-treated patients with diffuse large B-cell lymphomaY Kusano, M Yokoyama, Y Terui, et al.
Blood Cancer Journal|May 13, 2017
Low absolute peripheral blood CD4+ T-cell count predicts poor prognosis in R-CHOP-treated patients with diffuse large B-cell lymphomaY Kusano, M Yokoyama, Y Terui, et al.
Chemical & Pharmaceutical Bulletin|February 1, 1996
Endothelin receptor antagonist triterpenoid, myriceric acid A, isolated from Myrica cerifera, and structure activity relationships of its derivativesK Sakurawi, F Yasuda, T Tozyo, et al.
The American Journal of Gastroenterology|August 5, 2000
Clinical implications of TT virus superinfection in patients with chronic hepatitis CH Watanabe, T Saito, O Kawamata, et al.
Biochemical and Biophysical Research Communications|March 3, 1998
Identification of a novel apoptosis-inducing factor derived from leukemic cells: endothelial interleukin-8, but not monocyte-derived, induces apoptosis in leukemic cellsY Terui, M Ikeda, H Tomizuka, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 25, 2008
CD5 expression is potentially predictive of poor outcome among biomarkers in patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP therapyD Ennishi, K Takeuchi, M Yokoyama, et al.
Cancer Research|December 3, 1999
NH2-terminal pentapeptide of endothelial interleukin 8 is responsible for the induction of apoptosis in leukemic cells and has an antitumor effect in vivoY Terui, H Tomizuka, Y Mishima, et al.
The Journal of Antibiotics|June 19, 1998
Terprenins, novel immunosuppressants produced by Aspergillus candidusT Kamigauchi, R Sakazaki, K Nagashima, et al.
Leukemia|March 5, 2010
Galectin-9 exhibits anti-myeloma activity through JNK and p38 MAP kinase pathwaysT Kobayashi, J Kuroda, E Ashihara, et al.
The Tohoku Journal of Experimental Medicine|April 24, 2001
Acute cholestatic hepatitis caused by a probable allergic reaction to paracetamol in an adolescentH Shinzawa, H Togashi, K Sugahara, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Blood Cancer Journal|April 22, 2017
Low absolute peripheral blood CD4+ T-cell count predicts poor prognosis in R-CHOP-treated patients with diffuse large B-cell lymphomaY Kusano, M Yokoyama, Y Terui, et al.
Blood Cancer Journal|May 13, 2017
Low absolute peripheral blood CD4+ T-cell count predicts poor prognosis in R-CHOP-treated patients with diffuse large B-cell lymphomaY Kusano, M Yokoyama, Y Terui, et al.
Chemical & Pharmaceutical Bulletin|February 1, 1996
Endothelin receptor antagonist triterpenoid, myriceric acid A, isolated from Myrica cerifera, and structure activity relationships of its derivativesK Sakurawi, F Yasuda, T Tozyo, et al.
The American Journal of Gastroenterology|August 5, 2000
Clinical implications of TT virus superinfection in patients with chronic hepatitis CH Watanabe, T Saito, O Kawamata, et al.
Biochemical and Biophysical Research Communications|March 3, 1998
Identification of a novel apoptosis-inducing factor derived from leukemic cells: endothelial interleukin-8, but not monocyte-derived, induces apoptosis in leukemic cellsY Terui, M Ikeda, H Tomizuka, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 25, 2008
CD5 expression is potentially predictive of poor outcome among biomarkers in patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP therapyD Ennishi, K Takeuchi, M Yokoyama, et al.
Cancer Research|December 3, 1999
NH2-terminal pentapeptide of endothelial interleukin 8 is responsible for the induction of apoptosis in leukemic cells and has an antitumor effect in vivoY Terui, H Tomizuka, Y Mishima, et al.
The Journal of Antibiotics|June 19, 1998
Terprenins, novel immunosuppressants produced by Aspergillus candidusT Kamigauchi, R Sakazaki, K Nagashima, et al.
Leukemia|March 5, 2010
Galectin-9 exhibits anti-myeloma activity through JNK and p38 MAP kinase pathwaysT Kobayashi, J Kuroda, E Ashihara, et al.
The Tohoku Journal of Experimental Medicine|April 24, 2001
Acute cholestatic hepatitis caused by a probable allergic reaction to paracetamol in an adolescentH Shinzawa, H Togashi, K Sugahara, et al.
Pageof 9